Toward Tailoring the Degradation Rate of Magnesium-Based Biomaterials for Various Medical Applications: Assessing Corrosion, Cytocompatibility and Immunological Effects.
cytocompatibility
hydrogen evolution
immunological effects
magnesium
microstructure
plasma electrolytic oxidation (PEO)
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
19 Jan 2021
19 Jan 2021
Historique:
received:
30
11
2020
revised:
11
01
2021
accepted:
13
01
2021
entrez:
22
1
2021
pubmed:
23
1
2021
medline:
7
9
2021
Statut:
epublish
Résumé
Magnesium (Mg)-based biomaterials hold considerable promise for applications in regenerative medicine. However, the degradation of Mg needs to be reduced to control toxicity caused by its rapid natural corrosion. In the process of developing new Mg alloys with various surface modifications, an efficient assessment of the relevant properties is essential. In the present study, a WE43 Mg alloy with a plasma electrolytic oxidation (PEO)-generated surface was investigated. Surface microstructure, hydrogen gas evolution in immersion tests and cytocompatibility were assessed. In addition, a novel in vitro immunological test using primary human lymphocytes was introduced. On PEO-treated WE43, a larger number of pores and microcracks, as well as increased roughness, were observed compared to untreated WE43. Hydrogen gas evolution after two weeks was reduced by 40.7% through PEO treatment, indicating a significantly reduced corrosion rate. In contrast to untreated WE43, PEO-treated WE43 exhibited excellent cytocompatibility. After incubation for three days, untreated WE43 killed over 90% of lymphocytes while more than 80% of the cells were still vital after incubation with the PEO-treated WE43. PEO-treated WE43 slightly stimulated the activation, proliferation and toxin (perforin and granzyme B) expression of CD8
Identifiants
pubmed: 33478090
pii: ijms22020971
doi: 10.3390/ijms22020971
pmc: PMC7835942
pii:
doi:
Substances chimiques
Coated Materials, Biocompatible
0
Magnesium Compounds
0
Magnesium
I38ZP9992A
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : SM 214/4-1
Organisme : Deutsche Forschungsgemeinschaft
ID : WA 1672/40-1
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
In Vivo. 2018 Mar-Apr;32(2):241-247
pubmed: 29475905
Acta Biomater. 2014 Nov;10(11):4561-4573
pubmed: 25034646
J Biomed Mater Res B Appl Biomater. 2012 Aug;100(6):1691-701
pubmed: 22566412
Acta Biomater. 2010 May;6(5):1749-55
pubmed: 20051271
Acta Biomater. 2013 Nov;9(10):8643-9
pubmed: 22963846
Acta Biomater. 2011 Apr;7(4):1452-9
pubmed: 21145436
J Biomim Biomater Tissue Eng. 2012 Feb 3;12:25-39
pubmed: 22408600
Acta Biomater. 2015 Sep;23:354-363
pubmed: 26073090
Biomaterials. 2006 Mar;27(9):1728-34
pubmed: 16246414
Int J Mol Sci. 2019 Sep 30;20(19):
pubmed: 31574947
Cells. 2020 Jul 22;9(8):
pubmed: 32707842
Acta Biomater. 2013 Feb;9(2):5411-20
pubmed: 23022544
Int J Mol Sci. 2019 Jan 10;20(2):
pubmed: 30634646
Bioact Mater. 2020 Mar 30;5(2):398-409
pubmed: 32258829